Tachykinins potently stimulate human small bowel blood flow: A laser Doppler flowmetry study in humans

Gut

Volumn 52, Issue 1, 2003, Pages 53-56

  Schmidt, Peter Thelin ^a   Lordal M ^a   Gazelius, B ^a   Hellstrom P M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ A; SUBSTANCE P; TACHYKININ;

ADULT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOTENSION; INTESTINE BLOOD FLOW; INTESTINE MUCOSA; LASER DOPPLER FLOWMETRY; MALE; MANOMETRY; MIGRATING MYOELECTRIC COMPLEX; PRIORITY JOURNAL; PULSE RATE; SKIN BLOOD FLOW; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA;

ADOLESCENT; ADULT; BLOOD PRESSURE; DIASTOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INTESTINAL MUCOSA; INTESTINE, SMALL; LASER-DOPPLER FLOWMETRY; MALE; MANOMETRY; MYOELECTRIC COMPLEX, MIGRATING; NEUROKININ A; PULSE; REGIONAL BLOOD FLOW; SKIN; STATISTICS, NONPARAMETRIC; STIMULATION, CHEMICAL; SUBSTANCE P;

EID: 0037216563     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.1.53     Document Type: Article

References (25)

1. Holzer P, Holzer-Petsche U. Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol Ther 1997;73:173-217.
2. Holzer P, Holzer-Petsche U. Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol Ther 1997;73:219-63.
3. Prokopiw I, McDonald TJ. Effects of tachykinins on the splanchnic circulation: A comparison of the dog and rat. Peptides 1994;15:1189-94.
4. Stewart-Lee A, Burnstock G. Actions of tachykinins on the rabbit mesenteric artery: Substance P and (GIpó,L.Pro9)SP6.11 are potent agonists for endothelial neurokinin-1 receptors. Br J Pharmacol 1989;97:1218-24.
5. Smith VC, Sagot MA, Couraud JY, et al. Localization of the neurokinin 1 (NK-1) receptor in the human antrum and duodenum. Neurosci Lett 1998;253:49-52.
6. Renzi D, Pellegrini B, Tonelli F, et al. Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine. Am J Pathol 2000;157:1511-22.
7. Goode T, O'Connell J, Anton P, et al. Neurokinin-1 receptor expression in inflammatory bowel disease: Molecular quantitation and localisation. Gut 2000;47:387-96.
8. Evans TW, Dixon CM, Clarke B, et al. Comparison of neurokinin A and substance P on cardiovascular and airway function in man. Br J Clin Pharmacol 1988;25:273-5.
9. Tornebrandt K, Nobin A, Owman C. Contractile and dilatory action of neuropeptides on isolated human mesenteric blood vessels. Peptides 1987;8:251-6.
10. Thollander M, Hellström PM, Svensson TH, et al. Haemodynamic changes in the small intestine correlate to migrating motor complex in humans. Eur J Gastroenterol Hepatol 1996;8:777-85.
11. Emmanuel AV, Kamm MA. Laser Doppler measurement of rectal mucosal blood flow. Gut 1999;45:64-9.
12. Emmanuel AV, Kamm MA. Laser Doppler flowmetry as a measure of extrinsic colonic innervation in functional bowel disease. Gut 2000;46:212-17.
13. Thollander M, Hellström PM, Gazelius B. Semi-invasive laser-Doppler flowmetry technique. New application for recordings of hemodynamics in combination with manometry of human small intestine. Int J Microcirc Clin Exp 1997;17:15-21.
14. Thollander M, Gazelius B, Hellström PM. Adrenergic modulation of small bowel haemodynamics in interdigestive motility state in man. Eur J Gastroenterol Hepatol 1999;11:257-65.
15. Fioramonti J, Bueno L. Relation between intestinal motility and mesenteric blood flow in the conscious dog. Am J Physiol 1984;246:G108-13.
16. Rasmussen L, Mortensen MB, Troensegaard P, et al. The variability of the incremental postprandial portal vein flow response is partly caused by a relationship between fasting flow rate and phase activity of the migrating motor complex. Eur J Gastroenterol Hepatol 1999;11:171-4.
17. Lördal M, Theodorsson E, Hellström PM. Tachykinins influence interdigestive rhythm and contractile strength of human small intestine. Dig Dis Sci 1997;42:1940-9.
18. Brodin E, Sjölund K, Håkanson R, et al. Substance P-containing nerve fibers are numerous in human but not in feline intestinal mucosa. Gastroenterology 1983;85:557-64.
19. Newby DE, Sciberras DG, Ferro CJ, et al. Substance P-induced vasodilatation is mediated by the neurokinin type 1 receptor but does not contribute to basal vascular tone in man. Br J Clin Pharmacol 1999;48:336-44.
20. Romerio SC, Linder L, Haefeli WE. Neurokinin-1 receptor antagonist R116301 inhibits substance P-induced venodilation. Clin Pharmacol Ther 1999;66:522-7.
21. Schaffalitzky DE, Muckadell OB, Aggestrup S, et al. Flushing and plasma substance P concentration during infusion of synthetic substance P in normal man. Scand J Gastroenterol 1986;21:498-502.
22. Mantyh CR, Gates TS, Zimmerman RP, et al. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci USA 1988;85:3235-9.
23. Mantyh CR, Vigna SR, Maggio JE, et al. Substance P binding sites on intestinal lymphoid aggregates and blood vessels in inflammatory bowel disease correspond to authentic NK-1 receptors. Neurosci Lett 1994;178:255-9.
24. Maconi G, Imbesi V, Bianchi PG. Doppler ultrasound measurement of intestinal blood flow in inflammatory bowel disease. Scandn J Gastroenterol 1996;31:590-3.
25. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001;120:652-68.